Publicacions en col·laboració amb investigadors/es de University of Innsbruck (16)

2024

  1. Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis

    Neuroepidemiology, Vol. 58, Núm. 2, pp. 120-133

  2. Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 5, pp. 410-418

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients

    Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 35, Núm. 1, pp. 12-27

  3. Corrigendum to “Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study” [Journal of the Neurological Sciences. 2023 Jun 15;449:120646] (Journal of the Neurological Sciences (2023) 449, (S0022510X23001065), (10.1016/j.jns.2023.120646))

    Journal of the Neurological Sciences

  4. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition

    Journal of the Neurological Sciences, Vol. 454

  5. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study

    Journal of the Neurological Sciences, Vol. 449

2022

  1. Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months after a Diagnosis of COVID-19

    Transplantation, Vol. 106, Núm. 5, pp. 1012-1023

  2. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151

  3. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions

    Journal of the Neurological Sciences, Vol. 427

  2. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis

    Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320

  3. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

    Neurology, Vol. 97, Núm. 14, pp. E1367-E1381

2020

  1. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983

2017

  1. Clinical manifestations of the anti-IgLON5 disease

    Neurology, Vol. 88, Núm. 18, pp. 1736-1743

2016

  1. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes

    Journal of Neurology, Vol. 263, Núm. 7, pp. 1349-1360